For Patients with Commercial Coverage
Nearly 9 out of 10 prescriptions for NEXIUM* get approved at the pharmacy nationwide—that's similar† to generic PPIs and more than other branded PPIs‡
NEXIUM is the only brand in its class with Preferred formulary status at all 3 of the nation's largest prescription benefit providers§1
√ =Tier 2; X = Tier 3, as defined by Express Scripts, Caremark, and Medco Health
Prescription approval rates do not imply comparable efficacy, safety, or FDA-approved indications.
*For insured patients with prescription coverage.
†Similar is defined as being within 3%
‡Source: Walters Kluwer Health, Dynamic Claims, July through September 2010 (last accessed December 2010). Data derived from Walters Kluwer Health Dynamic Claims Database, a representative panel of over 51,000 unique retail pharmacies covering 4100 plans and affiliates.
§Individual benefit design may vary.
Source: Fingertip Formulary, December 15, 2010
║Caremark Formularies (Primary and Performance).
¶Express National Preferred and Prime Formularies
#Medco Standard Formularies (Primary Prescriptions® and Rx SelectionsTM)
Formulary comparisons do not imply comparable efficacy, safety, or FDA-approved indications.
AstraZeneca does not endorse any individual plan or provider.
Aciphex is a registered trademark of Eisai Co., Ltd. Zegerid is a registered trademark of Santarus, Inc. Dexilant is a trademark of Takeda Pharmaceuticals North America, Inc., and is used under license by Takeda Pharmaceuticals America, Inc. Fingertip Formulary is a registered trademark of Fingertip Formulary, LLC. Express Scripts is a registered trademark of Express Scripts, Inc. Preferred Prescriptions is a registered trademark and Rx Selections is a trademark of Medco Health Solutions, Inc.
Next: Medicare Part D Coverage
